NCT02906982

Brief Summary

The purpose of this study is to evaluate the efficacy of a novel gum health formulation, when used in an intra-oral device or on a toothbrush, for teeth whitening and clinical improvements in periodontal diseases.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
30

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Oct 2015

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

October 1, 2015

Completed
2 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2015

Completed
4 months until next milestone

Study Completion

Last participant's last visit for all outcomes

April 1, 2016

Completed
6 months until next milestone

First Submitted

Initial submission to the registry

September 13, 2016

Completed
7 days until next milestone

First Posted

Study publicly available on registry

September 20, 2016

Completed
Last Updated

September 20, 2016

Status Verified

September 1, 2016

Enrollment Period

2 months

First QC Date

September 13, 2016

Last Update Submit

September 15, 2016

Conditions

Keywords

Periodontal diseasesPeriodontitisGingivitisTeeth WhiteningDental Plaque IndexPeriodontal IndexTeeth Whitening AgentsTooth DiscolorationMean Probing DepthPocket Depth

Outcome Measures

Primary Outcomes (1)

  • Change from Baseline Tooth Shade Value over 45 Days

    Tooth Shade Value was measured using a Vita Shade Guide and the measurement was transformed to a standardized value.

    Baseline, Day 14, Day 28, Day 45

Secondary Outcomes (4)

  • Plaque Index

    Baseline, Day 14, Day 28, Day 45

  • Gingival Index

    Baseline, Day 14, Day 28, Day 45

  • Bleeding Index

    Baseline, Day 14, Day 28, Day 45

  • Mean Probing Depth

    Baseline, Day 14, Day 28, Day 45

Study Arms (3)

Gum health formulation in intra-oral device

EXPERIMENTAL

The interventional gum health formulation is applied to the participant's mouth by means of an intra-oral device for a single eight-minute application, daily. Participants instructed to brush their teeth with a toothbrush and toothpaste twice daily, morning and night.

Other: Gum health formulation in intra-oral device

Gum health formulation on toothbrush

EXPERIMENTAL

The interventional gum health formulation is applied to the participant's mouth by means of a toothbrush and toothpaste, plus the gum health formulation, for two-minute applications, twice daily, morning and night.

Other: Gum health formulation on toothbrush

Control group (split-mouth design)

NO INTERVENTION

The control group did not receive the interventional gum health formulation. Participants instructed to brush their teeth with a toothbrush and toothpaste twice daily, morning and night. In addition, participants instructed to floss only half of their mouth daily, and the non-flossed half serves as the untreated comparative control receiving no intervention.

Interventions

The intervention is a gum health formulation for periodontal disease care and teeth whitening to be used within an accelerating intra-oral device.

Also known as: ECO Balance, GLO Science intra-oral accelerating device
Gum health formulation in intra-oral device

The intervention is a gum health formulation for periodontal care and teeth whitening to be used on a toothbrush alongside standard toothpaste.

Also known as: ECO Balance
Gum health formulation on toothbrush

Eligibility Criteria

Age18 Years - 65 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Willing and able to read, understand and sign an Informed Consent form
  • Good general health as evidenced by the medical history
  • Between 18 and 65 years of age
  • A minimum of 20 teeth, excluding crowns and third molar teeth
  • A mean whole mouth Gingival Index score of \>2.0 at baseline
  • Sites with \<7mm pocket depth
  • Willing to abstain from all oral hygiene procedures for 12-18 hours prior to clinical visits
  • Willing to abstain from eating and drinking in the morning of visits, only drinking water
  • Willing to abstain from chewing gums, oral whitening products, mouthwashes and tobacco products for the study duration
  • Ability to understand and follow study protocol
  • No known history of allergy to dairy products or their ingredients, relevant to any ingredient in the test products

You may not qualify if:

  • Chronic use of photosensitizing medications including NSAIDs, antidepressants, antibiotics and beta blockers
  • Diagnosis of diabetes mellitus
  • Presence of orthodontic appliances
  • Presence of large restorations
  • Crown or veneer at the anterior of both upper and lower teeth (including premolar teeth)
  • A soft or hard tissue tumor of the oral cavity
  • Carious lesions
  • Severe internal (tetracycline stains) and external discolouration (fluorosis)
  • Diagnosis of severe chronic periodontitis, aggressive periodontitis, acute necrotizing ulcerative gingivitis or generalized gingival recession \>2mm as evidenced by clinical oral exam
  • Participating in another clinical trial or oral product study
  • Pregnant or breast-feeding women
  • Allergy to home bleaching products such as hydrogen peroxide and carbamide peroxide
  • Use of antibiotics within 3 months of enrolment
  • History of drug use that is associated with gum overgrowth (i.e., Dilantin, nifedipine, etc.)
  • Chronic use of medication such as steroids, anti-coagulant medications, immunosuppressant medications or any other medications or medical conditions that in the opinion of the investigator would interfere with the evaluation or confound interpretation of the study results
  • +3 more criteria

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

EEC Institute, Inc.

New York, New York, 10016, United States

Location

MeSH Terms

Conditions

Tooth DiscolorationPeriodontal DiseasesPeriodontitisGingivitis

Condition Hierarchy (Ancestors)

Tooth DiseasesStomatognathic DiseasesMouth DiseasesInfectionsGingival Diseases

Study Officials

  • Edgard El Chaar, DDS, MS

    EEC Institute, Inc.

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
INDUSTRY
Responsible Party
SPONSOR

Study Record Dates

First Submitted

September 13, 2016

First Posted

September 20, 2016

Study Start

October 1, 2015

Primary Completion

December 1, 2015

Study Completion

April 1, 2016

Last Updated

September 20, 2016

Record last verified: 2016-09

Locations